Literature DB >> 15172658

Electroanatomic mapping and ablation of ventricular tachycardia associated with systemic sclerosis.

Dominique Lacroix1, François Brigadeau, Christelle Marquié, Didier Klug.   

Abstract

Two cases of systemic sclerosis with sustained ventricular tachycardia (VT) are presented. The first patient received hydroxychloroquine for skeletal muscle disease coexisting with cardiac involvement. In both cases, 3D-electroanatomic mapping showed low-voltage areas in the right ventricle. In the first patient the tachycardia was mapped and a protected isthmus suggesting reentry was delineated and ablated. Other substrate locations were indirectly identified by pacemapping on the right and left ventricular endocardium in the second patient. VT did not reoccur during follow-up. Radiofrequency catheter ablation is safe and effective and electroanatomic mapping may be helpful in patients with systemic sclerosis.

Entities:  

Mesh:

Year:  2004        PMID: 15172658     DOI: 10.1016/j.eupc.2004.03.012

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  4 in total

1.  Electrical storm in systemic sclerosis: Inside the electroanatomic substrate.

Authors:  Michela Casella; Corrado Carbucicchio; Eleonora Russo; Francesca Pizzamiglio; Paolo Golia; Sergio Conti; Fabrizio Costa; Antonio Dello Russo; Claudio Tondo
Journal:  World J Cardiol       Date:  2014-10-26

2.  Radiofrequency catheter ablation of hemodynamically unstable ventricular tachycardia associated with systemic sclerosis.

Authors:  Hoe-Hoon Chung; Jin-Bae Kim; Sung-Hoon Hong; Hong-Joo Lee; Boyoung Joung; Moon-Hyoung Lee
Journal:  J Korean Med Sci       Date:  2012-01-27       Impact factor: 2.153

Review 3.  Arrhythmias and Conduction Disturbances in Autoimmune Rheumatic Disorders.

Authors:  Sotiris C Plastiras; Haralampos M Moutsopoulos
Journal:  Arrhythm Electrophysiol Rev       Date:  2021-04

4.  Electrocardiographic markers for the prediction of ventricular arrhythmias in patients with systemic sclerosis.

Authors:  Veronika Sebestyén; Gabriella Szűcs; Dénes Páll; Dóra Ujvárosy; Tamás Ötvös; Imre Csige; Tamás Pataki; István Lőrincz; Zoltán Szabó
Journal:  Rheumatology (Oxford)       Date:  2020-03-01       Impact factor: 7.580

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.